May 02, 2016
1 min read

Preoperative opioid use linked with lower outcome scores after TSA

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Patients with a history of preoperative opioid use experienced significantly lower preoperative baseline and final outcome scores after total shoulder arthroplasty than patients who did not take opioids preoperatively, according to results.

Researchers retrospectively compared data for 60 patients with a history of preoperative opioid use for shoulder pain who underwent total shoulder arthroplasty (TSA) to a control group of 164 patients who did not take opioids preoperatively. Researchers assessed patient-reported outcome measurements, range of motion and patient satisfaction preoperatively and at most recent follow-up.

Brent J. Morris


Results showed significantly lower preoperative scores for all patient-reported outcome measurements except for the Single Assessment Numeric Evaluation (SANE) score among patients in the opioid group. Although patient-reported outcome measurements and range of motion significantly improved from preoperative values to most recent follow-up in both groups, researchers found the preoperative opioid group had significantly lower scores in all patient-reported outcomes measurements except the SANE score and significantly lower range of motion measurements except for external rotation.

Preoperative opioid use was associated with significantly lower preoperative and postoperative Constant scores for pain, activity, mobility and strength; lower total Constant score; lower adjusted Constant score; lower American Shoulder and Elbow Surgeons (ASES) score; lower ASES score for pain; and lower Western Ontario Osteoarthritis Shoulder index, according to results. Researchers noted 80% of patients in the preoperative opioid group were satisfied with their surgery vs. 91% in the non-opioid group. – by Casey Tingle


Disclosures: Morris is a consultant for Tornier Inc. Please see the full study for a list of all other authors’ relevant financial disclosures.